Tabriz University of Medical Sciences Journal of Cardiovascular and Thoracic Research 2008-5117 13 1 2021 02 28 Coagulopathy: Another side effect of coronavirus infection 15 22 10.34172/jcvtr.2020.59 EN Fatemeh Sadoughi Parisa Maleki Dana Jamal Hallajzadeh https://orcid.org/0000-0003-0696-9229 Zatollah Asemi https://orcid.org/0000-0001-5265-4792 Mohammad Ali Mansournia Bahman Yousefi REVIEW 10.34172/jcvtr.2020.59 2020 05 30 2020 11 02 Recently, coronavirus disease 2019 (COVID-19) has been considered as a major health problem around the globe. This severe acute respiratory syndrome has a bunch of features, such as high transmission rate, which are adding to its importance. Overcoming this disease relies on a complete understanding of the viral structure, receptors, at-risk cells or tissues, and pathogenesis. Currently, researches have shown that besides the lack of a proper anti-viral therapeutic method, complications provided by this virus are also standing in the way of decreasing its mortality rate. One of these complications is believed to be a hematologic manifestation. Commonly, three kinds of coagulopathies are detected in COVID-19 patients: disseminated intravascular coagulation (DIC), pulmonary embolism (PE), and deep vein thrombosis (DVT). In this paper, we have reviewed the relation between these conditions and coronavirus-related diseases pathogenesis, severity, and mortality rate.